Facebook Pixel Code

Kopran Share Price

NSE
BSE

Here's the live share price of Kopran along with daily highs, lows, percentage changes and volume trends, and, all financial information.

₹178.00 Closed
3.25₹ 5.6
As on Sep 23, 2025, 4:01 PM IST
Intraday
1W
1M
3M
6M
YTD
1Y
3Y
5Y
10Y

Kopran Price Performance

Today's LowToday's High
₹171.10₹180.15
₹178.00
52 Weeks' Low52 Weeks' High
₹154.05₹357.35
₹178.00
Open Price
₹175.80
Prev. Close
₹172.40
Volume
33,825

Over the last 5 years, the share price of Kopran has gained 17.00% CAGR. Over the past year, the corresponding return has been -48.06%.

Kopran’s current P/E of 24.62x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.

Kopran Peer Comparision

Stock Performance
Ratio Performance
Name
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
Kopran
0.9612.37-0.45-6.54-48.322.2817.00
Sun Pharmaceutical Industries
0.67-1.54-1.81-8.63-12.6921.0026.54
Divi's Laboratories
-0.23-3.36-8.062.1512.3618.3513.97
Torrent Pharmaceuticals
3.38-0.2115.2912.385.4234.2122.46
Cipla
-2.01-4.571.670.23-6.6912.6914.78
Dr. Reddy's Laboratories
-0.221.83-2.198.11-1.6616.475.10
Mankind Pharma
-0.340.1010.917.91-6.2721.5912.45
Zydus Lifesciences
1.022.158.3412.82-0.6143.1322.18
Lupin
-1.411.943.72-5.60-9.5645.6314.54
Alkem Laboratories
1.662.7915.8110.16-7.9419.5415.21
Aurobindo Pharma
1.173.910.46-8.30-26.2028.937.27
Abbott India
-2.25-4.05-4.00-2.657.0419.2213.60
Glenmark Pharmaceuticals
-1.163.2020.0035.1818.8973.8133.80
Laurus Labs
1.914.3036.0346.0693.7321.2727.22
Biocon
1.610.043.213.08-4.048.22-3.20
GlaxoSmithKline Pharmaceuticals
0.83-1.46-14.53-4.321.5825.2411.64
Anthem Biosciences
-4.92-2.6012.4212.4212.423.982.37
Ipca Laboratories
5.72-0.933.93-4.52-6.4916.655.37
Cohance Lifesciences
-6.990.09-8.74-23.33-24.1327.2919.61
Gland Pharma
1.313.7114.0124.918.58-2.132.04

Over the last one year, Kopran has declined 48.32% compared to peers like Sun Pharmaceutical Industries (-12.69%), Divi's Laboratories (12.36%), Torrent Pharmaceuticals (5.42%). From a 5 year perspective, Kopran has outperformed peers relative to Sun Pharmaceutical Industries (26.54%) and Divi's Laboratories (13.97%).

Kopran Financials

Consolidated
Standalone
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Income Statement
Ratios

Kopran Stock Technicals

Moving Average

DaySMAEMA
5174.99174.04
10178174.31
20170.13172.23
50168.91171.8
100178.01177.22
200185.29191.39

Kopran Share Holding Pattern

In the latest quarter, Kopran saw a drop in promoter holding to 44.42%, while DII stake unchanged at 0.00%, FII holding fell to 0.76%, and public shareholding moved up to 54.81% compared to the previous quarter — reflecting a shift in investor sentiment across categories.

Kopran Stock Mutual Fund Holdings

Fund Name
No. Of Shares
% of AUM
Amount Invested(in ₹ crore)
Motilal Oswal BSE Healthcare ETF6480.030.01

Kopran Corporate Actions

Date Time
Announcement
Sep 18, 2025, 7:51 PM ISTKopran Ltd - Announcement under Regulation 30 (LODR)-Change in Management
Sep 11, 2025, 11:44 PM ISTKopran Ltd - Shareholder Meeting / Postal Ballot-Outcome of AGM
Sep 02, 2025, 7:40 PM ISTKopran Ltd - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
Aug 16, 2025, 3:52 PM ISTKopran Ltd - Reg. 34 (1) Annual Report.
Aug 16, 2025, 3:22 PM ISTKopran Ltd - Business Responsibility and Sustainability Reporting (BRSR)

About Kopran

Kopran Ltd. is a Public Limited Listed company incorporated on 26/04/1958 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24230MH1958PLC011078 and registration number is 011078. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 271.01 Cr. and Equity Capital is Rs. 48.29 Cr. for the Year ended 31/03/2025.

Management

  • Mr. Susheel G Somani
    Chairman
  • Mr. Surendra Somani
    Executive Vice Chairman
  • Mr. Adarsh Somani
    Director
  • Mr. Varun Somani
    Director
  • Dr. Siddhan Subramanian
    Independent Director
  • Dr. Sunita Banerji
    Independent Director
  • Mrs. Mamta Biyani
    Independent Director
  • Mr. Narayan Atal
    Independent Director

FAQs on Kopran Share Price

What is the share price of Kopran?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Kopran is ₹178.00 as on Sep 23, 2025.

What kind of stock is Kopran?

The Kopran is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.

What is the Market Cap of Kopran?

The market cap of Kopran is ₹859.48 Cr as on Sep 23, 2025.

What are today's High and Low prices of Kopran?

Today’s highest and lowest price of Kopran are ₹180.15 and ₹171.10.

What are the 52 Week High and 52 Week Low of Kopran?

The 52-week high/low is the highest and lowest price at which Kopran stock has traded in the past 52-week or nearly a year. The 52-week high of Kopran is ₹357.35 and 52-week low of Kopran is ₹154.05 as on Sep 23, 2025.

How has the Kopran performed historically in terms of returns?

The Kopran has shown returns of 3.25% over the past day, 12.37% for the past month, 1.22% over 3 months, -48.06% over 1 year, 2.28% across 3 years, and 17.0% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Kopran?

P/E ratio of and PB ratio of Kopran are 24.62 and 1.66 on Sep 23, 2025. While the company gives a dividend yield of 1.69 per annum.

icon
Market Data